Richardson Electronics (RELL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for October 7, 2025, to vote on director elections, auditor ratification, executive compensation, amendments to the long-term incentive plan, and an increase in authorized shares.
Proxy materials are distributed electronically, with voting available by phone, internet, or mail for shareholders of record as of August 8, 2025.
The board recommends voting in favor of all proposals, including director nominees, auditor ratification, executive compensation, incentive plan amendment, and certificate of incorporation amendment.
Voting matters and shareholder proposals
Seven directors are nominated for election for a term expiring at the 2026 annual meeting.
Proposals include ratification of BDO USA, P.C. as auditor, advisory approval of executive compensation, amendment to increase shares under the 2011 Long-Term Incentive Plan, and an increase in authorized common stock.
Shareholders may submit proposals for the 2026 meeting by April 24, 2026, and director nominations by July 14, 2026.
Board of directors and corporate governance
The board consists of seven directors, with a mix of industry, financial, and management experience.
Five directors are independent per Nasdaq standards; all committee members are independent.
The roles of Chairman and CEO are combined; a lead independent director is appointed.
Four standing committees: Audit, Compensation & Governance, Executive, and Nominating.
Non-employee directors receive equity awards, cash retainers, and must meet stock ownership guidelines.
Latest events from Richardson Electronics
- Sales and profits fell in 2024, but margin, cash flow, and backlog support a positive 2025 outlook.RELL
Q4 20242 Feb 2026 - Q1 FY25 sales up 2.2% to $53.7M, with GES and Healthcare growth and a strong, debt-free balance sheet.RELL
Q1 202519 Jan 2026 - Q3 net sales up 2.7% YoY, strong PMT/Canvys, $4.9M Healthcare loss, cash $36.7M, no debt.RELL
Q3 202516 Jan 2026 - Q2 FY25 sales up 12.1% to $49.5M, led by 129% GES growth and improved margins.RELL
Q2 202510 Jan 2026 - Q2 FY26 sales up 5.7% to $52.3M, GES up 39%, net loss narrows, $0.06 dividend declared.RELL
Q2 20268 Jan 2026 - Proxy seeks approval for director elections, auditor, compensation, and share increases.RELL
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and executive pay are key 2024 meeting topics.RELL
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve executive pay on October 8, 2024.RELL
Proxy Filing1 Dec 2025 - Definitive proxy statement filed for shareholder voting, with no fee required.RELL
Proxy Filing1 Dec 2025